EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

HDR Endorectal/Endoluminal Brachytherapy Boost in Rectal Organ Preservation: A Systematic Review and Meta-Analysis

Yuanjie Cao iD, Chen Li, Baozhong Zhang, Jie Chen

Cancers · 06.05.2026 · 18 (9) · 1494

DOI: 10.3390/cancers18091494 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 06.05.2026. Verfasst von Yuanjie Cao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University Cancer Institute & Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose: Organ-preservation strategies are increasingly being incorporated into rectal cancer management, but the role of HDR endorectal/endoluminal brachytherapy boost remains less well defined than that of broader non-operative treatment pathways. Existing literature is frequently mixed with contact X-ray brachytherapy series, neoadjuvant protocols with planned surgery, or heterogeneous watch-and-wait cohorts, limiting the interpretation of this specific strategy. Materials and methods: We performed a PROSPERO-registered systematic review and meta-analysis of studies evaluating definitive-intent external beam radiotherapy (EBRT), with or without chemotherapy, followed by HDR endorectal/endoluminal brachytherapy boost in histologically confirmed rectal adenocarcinoma managed without planned surgery. Pooled analyses were performed for clinical complete response (cCR) and late grade ≥3 gastrointestinal (GI) toxicity. Regrowth/local failure outcomes were synthesized descriptively because of heterogeneity in endpoint definitions, denominator selection, and follow-up structure.

Results

Six studies were included in the quantitative evidence base, with one additional small feasibility report summarized narratively. The pooled cCR proportion was 69.2% (95% confidence interval [CI], 43.7–86.6). The pooled proportion of late grade ≥3 GI toxicity was 18.1% (95% CI, 10.9–28.6). Reported regrowth/local failure outcomes were not suitable for formal pooling because of inconsistent definitions, differing denominator structures, and non-uniform follow-up frameworks across studies.

Conclusion

Current evidence suggests that EBRT plus HDR endorectal/endoluminal brachytherapy boost may represent a selective organ-preservation strategy for carefully chosen patients with rectal adenocarcinoma, particularly where surgery is not feasible or not desired. Its broader clinical use remains limited not only by the small size of the evidence base, but also by fragmented endpoint definitions, inconsistent denominator reporting, and insufficiently standardized durable local-control outcomes. These findings support cautious interpretation of the current evidence and highlight priorities for future prospective studies in rectal cancer management.

Schlagwörter

Stichwörter der Autor:innen

HDR brachytherapydose escalationendorectal brachytherapynon-operative managementorgan preservationrectal cancer

Autor:innen und Institutionen

  • Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China.
  • Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin 300060, China.

ORCID-Profile: Yuanjie Cao

Förderung

  • Tianjin Medical University Cancer Institute and Hospital
  • Tianjin Medical University Cancer Institute & Hospital

Zitieren

APA

Cao, Y., Li, C., Zhang, B., & Chen, J. (2026). HDR Endorectal/Endoluminal Brachytherapy Boost in Rectal Organ Preservation: A Systematic Review and Meta-Analysis. Cancers, 18(9), 1494. https://doi.org/10.3390/cancers18091494

Vancouver

Cao Y, Li C, Zhang B, Chen J. HDR Endorectal/Endoluminal Brachytherapy Boost in Rectal Organ Preservation: A Systematic Review and Meta-Analysis. Cancers. 2026;18(9):1494. doi:10.3390/cancers18091494

BibTeX
@article{Cao2026,
  author = {Cao, Yuanjie and Li, Chen and Zhang, Baozhong and Chen, Jie},
  title = {HDR Endorectal/Endoluminal Brachytherapy Boost in Rectal Organ Preservation: A Systematic Review and Meta-Analysis},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {9},
  pages = {1494},
  doi = {10.3390/cancers18091494}
}
Kostenlos starten →